Home
/
GRI Bio, Inc.
/
Financials
/
Quarterly
GRI Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GRI Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2022
Mar 31, 2022
$0
May 9, 2022
Q3
2021
Sep 30, 2021
$0
Nov 12, 2021
Q2
2021
Jun 30, 2021
$0
Aug 10, 2021
Q1
2022
Mar 31, 2021
$0
May 9, 2022
Q3
2021
Sep 30, 2020
$0
Nov 12, 2021
Q2
2021
Jun 30, 2020
$0
Aug 10, 2021
Q1
2021
Mar 31, 2020
$100.0K
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.36M)
Nov 14, 2025
Q3
2025
Jun 30, 2025
($2.89M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.89M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.05M)
May 15, 2025
Q2
2025
Mar 31, 2025
($3.05M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($3.05M)
Nov 14, 2025
Q3
2025
Sep 30, 2024
($2.12M)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($2.25M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.25M)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($1.89M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.89M)
May 15, 2025
Q3
2025
Mar 31, 2024
($1.89M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($2.14M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($6.75M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($6.75M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($2.15M)
May 10, 2024
Q2
2024
Mar 31, 2023
($2.15M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($2.15M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($351.0K)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($295.0K)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.37M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.90M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.05M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.13M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.26M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.90M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.44M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($5.93M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($988.0K)
May 10, 2024
Q3
2023
Sep 30, 2022
($186.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($189.0K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.63M)
May 15, 2023
Q3
2022
Sep 30, 2021
($1.25M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($2.31M)
Jul 28, 2022
Q1
2022
Mar 31, 2021
($2.60M)
May 9, 2022
Q3
2021
Sep 30, 2020
($1.03M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.14M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($1.16M)
May 13, 2021